QRS Duration Is Associated With Atrial Fibrillation in Patients With Left Ventricular Dysfunction
暂无分享,去创建一个
Heather Bush | Candace J. Brancato | D. Delurgio | J. Langberg | A. León | Angel R Leon | David B Delurgio | Mikhael F El-Chami | Candace Brancato | Jonathan Langberg | Lynne Brosius | Lynne Brosius | Mikhael F. El-Chami | H. Bush
[1] R E Brashear,et al. Arrhythmias in patients with chronic obstructive pulmonary disease. , 1984, The Medical clinics of North America.
[2] S. Perrone,et al. Which Patients with Congestive Heart Failure May Benefit from Biventricular Pacing? , 2003, Pacing and clinical electrophysiology : PACE.
[3] W. Grimm,et al. How Many Patients with Dilated Cardiomyopathy May Potentially Benefit from Cardiac Resynchronization Therapy? , 2003, Pacing and clinical electrophysiology : PACE.
[4] K. Swedberg,et al. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). , 1988, The American journal of cardiology.
[5] U. Laufs,et al. Prevention of Atrial Fibrillation With 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors , 2008, Circulation.
[6] L H Kuller,et al. Incidence of and risk factors for atrial fibrillation in older adults. , 1997, Circulation.
[7] M A Waclawiw,et al. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction. , 1998, Journal of the American College of Cardiology.
[8] M. Bourassa. Angiotensin II inhibition and prevention of atrial fibrillation and stroke. , 2005, Journal of the American College of Cardiology.
[9] P. Zimetbaum,et al. Arrhythmias in Patients With Chronic Obstructive Pulmonary Disease (COPD): Occurrence Frequency and the Effect of Treatment With the Inhaled Long-Acting Beta2-Agonists Arformoterol and Salmeterol , 2008, Medicine.
[10] R. Prescott,et al. Cardiac size, autonomic function, and 5-year follow-up of chronic heart failure patients with severe prolongation of ventricular activation. , 2003, Journal of cardiac failure.
[11] W. Kannel,et al. The natural history of congestive heart failure: the Framingham study. , 1971, The New England journal of medicine.
[12] J. De Sutter,et al. Relationship between QRS duration, left ventricular volumes and prevalence of nonviability in patients with coronary artery disease and severe left ventricular dysfunction , 2006, European journal of heart failure.
[13] G. Somes,et al. On the relationship between heart weights, fibrosis, and QRS duration. , 1975, Journal of electrocardiology.
[14] S. Solomon,et al. Association of QRS duration and outcomes after myocardial infarction: the VALIANT trial. , 2006, Heart rhythm.
[15] A. Camm,et al. Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group. , 1999, The New England journal of medicine.
[16] C. Yancy,et al. Temporal trends in clinical characteristics, treatments, and outcomes for heart failure hospitalizations, 2002 to 2004: findings from Acute Decompensated Heart Failure National Registry (ADHERE). , 2007, American heart journal.
[17] K. Iwakura,et al. New approach to the estimation of the extent of myocardial fibrosis in patients with dilated cardiomyopathy: use of signal-averaged electrocardiography. , 1993, American heart journal.
[18] Luigi Tavazzi,et al. Left bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: a report from the Italian network on congestive heart failure. , 2002, American heart journal.
[19] Salim Yusuf,et al. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.
[20] I. V. Van Gelder,et al. Gender-related differences in rhythm control treatment in persistent atrial fibrillation: data of the Rate Control Versus Electrical Cardioversion (RACE) study. , 2005, Journal of the American College of Cardiology.
[21] W. Kannel,et al. Incidence and Epidemiology of Heart Failure , 2000, Heart Failure Reviews.
[22] K. Swedberg,et al. Clinical implications of QRS duration in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction. , 2008, JAMA.
[23] K. Kimura,et al. Relation of atrial fibrillation to glomerular filtration rate. , 2008, The American journal of cardiology.
[24] A. Auricchio,et al. Potential benefit of biventricular pacing in patients with congestive heart failure and ventricular tachyarrhythmia. , 1999, The American journal of cardiology.
[25] J. McMurray,et al. Antiarrhythmic effect of carvedilol after acute myocardial infarction: results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial. , 2005, Journal of the American College of Cardiology.
[26] E. Benjamin,et al. Current perceptions of the epidemiology of atrial fibrillation. , 2009, Cardiology clinics.
[27] I. V. Van Gelder,et al. New risk factors for atrial fibrillation: causes of 'not-so-lone atrial fibrillation'. , 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[28] S Nattel,et al. Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort. , 1999, Circulation.
[29] J. Langberg,et al. The relationship between stature and the prevalence of atrial fibrillation in patients with left ventricular dysfunction. , 2006, Journal of the American College of Cardiology.
[30] J. Langberg,et al. Lipid-lowering drug use is associated with reduced prevalence of atrial fibrillation in patients with left ventricular systolic dysfunction. , 2006, Heart rhythm.
[31] David Cunnington,et al. Prevalence of sleep disordered breathing in paroxysmal and persistent atrial fibrillation patients with normal left ventricular function. , 2008, European heart journal.
[32] P. McCullough,et al. Congestive heart failure and QRS duration: establishing prognosis study. , 2002, Chest.
[33] W. Stevenson,et al. Atrial fibrillation and heart failure--five more years. , 2004, The New England journal of medicine.
[34] W. Stevenson,et al. Atrial fibrillation in heart failure: high mortality risk even if ventricular function is preserved. , 2005, American heart journal.
[35] S. Barold,et al. Significance of QRS complex duration in patients with heart failure. , 2005, Journal of the American College of Cardiology.
[36] G. Dangas,et al. A prolonged QRS duration on surface electrocardiogram is a specific indicator of left ventricular dysfunction [see comment]. , 1998, Journal of the American College of Cardiology.
[37] V. Somers,et al. Atrial fibrillation and obesity--results of a meta-analysis. , 2008, American heart journal.
[38] Paul J. Wang,et al. Echocardiographic evidence of left atrial abnormality in young patients with lone paroxysmal atrial fibrillation. , 2004, The American journal of cardiology.
[39] R. Sandhu,et al. Prevalence of QRS prolongation in a community hospital cohort of patients with heart failure and its relation to left ventricular systolic dysfunction. , 2004, The American journal of cardiology.
[40] A. Cohen-Solal,et al. Heart failure and diabetes mellitus: epidemiology and management of an alarming association. , 2008, Journal of cardiac failure.
[41] P. Hildebrandt,et al. Prevalence and prognostic significance of atrial fibrillation in outpatients with heart failure due to left ventricular systolic dysfunction , 2007, European journal of heart failure.
[42] P C Deedwania,et al. Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: observations from the veterans affairs congestive heart failure survival trial of antiarrhythmic therapy (CHF-STAT). The Department of Veterans Affairs CHF-STAT Investigators. , 1998, Circulation.
[43] A. Costard-Jäckle. [Atrial fibrillation in heart failure]. , 2002, Herz.
[44] S G Thompson,et al. Incidence and aetiology of heart failure; a population-based study. , 1999, European heart journal.
[45] A. Go,et al. Racial variation in the prevalence of atrial fibrillation among patients with heart failure: the Epidemiology, Practice, Outcomes, and Costs of Heart Failure (EPOCH) study. , 2004, Journal of the American College of Cardiology.
[46] J. Floras,et al. Obstructive sleep apnoea and its cardiovascular consequences , 2009, The Lancet.
[47] S. Anker,et al. Clinical characteristics and survival of patients with chronic heart failure and prolonged QRS duration. , 2002, International journal of cardiology.
[48] Silvia G. Priori,et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text , 2006 .
[49] S. Perlini,et al. Prevention of recurrent lone atrial fibrillation by the angiotensin-II converting enzyme inhibitor ramipril in normotensive patients. , 2009, Journal of the American College of Cardiology.